loadpatents
name:-0.058586120605469
name:-0.028812170028687
name:-0.013272047042847
KUNZER; Aaron R. Patent Filings

KUNZER; Aaron R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KUNZER; Aaron R..The latest application filed is for "apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases".

Company Profile
13.37.69
  • KUNZER; Aaron R. - Arlington Heights IL
  • Kunzer; Aaron R. - Schaumburg IL
  • Kunzer; Aaron R. - Arlington Heighs IL
  • Kunzer; Aaron R. - Shaumburg IL
  • Kunzer; Aaron R. - Arlington Height IL
  • Kunzer; Aaron R - Schaumburg IL
  • Kunzer; Aaron R. - Vernon Hills IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210346369 - WANG; Le ;   et al.
2021-11-11
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210228565 - Wang; Le ;   et al.
2021-07-29
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210221789 - Bruncko; Milan ;   et al.
2021-07-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200345717 - WANG; Le ;   et al.
2020-11-05
Macrocyclic MCL-1 Inhibitors and Methods of Use
App 20200325153 - Judd; Andrew S. ;   et al.
2020-10-15
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200253954 - Kind Code
2020-08-13
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20200246460 - Kind Code
2020-08-06
Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors
App 20200246323 - Kind Code
2020-08-06
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same
App 20200239553 - Ackler; Scott L. ;   et al.
2020-07-30
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200231566 - Bruncko; Milan ;   et al.
2020-07-23
Macrocyclic MCL-1 inhibitors and methods of use
Grant 10,676,485 - Judd , et al.
2020-06-09
Macrocyclic MCL-1 Inhibitors and Methods of Use
App 20200010480 - Brady; Patrick B. ;   et al.
2020-01-09
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20190142941 - Ackler; Scott L. ;   et al.
2019-05-16
Macrocyclic MCL-1 inhibitors and methods of use
App 20190144465 - Judd; Andrew S. ;   et al.
2019-05-16
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20190119247 - Bruncko; Milan ;   et al.
2019-04-25
Macrocyclic MCL-1 inhibitors and methods of use
App 20190055264 - Brady; Patrick B. ;   et al.
2019-02-21
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180251426 - Bruncko; Milan ;   et al.
2018-09-06
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180221363 - WANG; Le ;   et al.
2018-08-09
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180140595 - Wang; Le ;   et al.
2018-05-24
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,877,958 - Wang , et al. January 30, 2
2018-01-30
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,844,547 - Wang , et al. December 19, 2
2017-12-19
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20170296531 - Wang; Le ;   et al.
2017-10-19
Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors
App 20170182179 - Ackler; Scott L. ;   et al.
2017-06-29
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20170158666 - Bruncko; Milan ;   et al.
2017-06-08
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20160339117 - Ackler; Scott L. ;   et al.
2016-11-24
Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases
Grant 9,493,431 - Kunzer , et al. November 15, 2
2016-11-15
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160304451 - Elmore; Steven W. ;   et al.
2016-10-20
Apoptosis-induced Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160206611 - Wang; Le ;   et al.
2016-07-21
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160158218 - Wang; Le ;   et al.
2016-06-09
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same
App 20160158377 - Ackler; Scott L. ;   et al.
2016-06-09
7-substituted indole Mcl-1 inhibitors
Grant 9,359,296 - Wang , et al. June 7, 2
2016-06-07
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,315,488 - Ding , et al. April 19, 2
2016-04-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,303,025 - Bruncko , et al. April 5, 2
2016-04-05
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,266,877 - Wang , et al. February 23, 2
2016-02-23
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20160009687 - Ding; Hong ;   et al.
2016-01-14
Apoptosis-inducing Agent For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160002187 - Kunzer; Aaron R. ;   et al.
2016-01-07
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,227,963 - Wang , et al. January 5, 2
2016-01-05
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150329541 - Bruncko; Milan ;   et al.
2015-11-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,174,982 - Bruncko , et al. November 3, 2
2015-11-03
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,156,856 - Kunzer , et al. October 13, 2
2015-10-13
7-substituted Indole Mcl-1 Inhibitors
App 20150284328 - Wang; Xilu ;   et al.
2015-10-08
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,125,913 - Bruncko , et al. September 8, 2
2015-09-08
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,072,748 - Bruncko , et al. July 7, 2
2015-07-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150183775 - BRUNCKO; Milan ;   et al.
2015-07-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150152097 - Wang; Le ;   et al.
2015-06-04
7-substituted indole Mcl-1 inhibitors
Grant 9,035,047 - Wang , et al. May 19, 2
2015-05-19
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150072978 - Wang; Le ;   et al.
2015-03-12
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,952,157 - Ding , et al. February 10, 2
2015-02-10
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,940,737 - Wang , et al. January 27, 2
2015-01-27
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,889,675 - Wang , et al. November 18, 2
2014-11-18
1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives
Grant 8,853,209 - Song , et al. October 7, 2
2014-10-07
Apoptosis Promoters
App 20140187531 - Bruncko; Milan ;   et al.
2014-07-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140113910 - Bruncko; Milan ;   et al.
2014-04-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140107119 - Bruncko; Milan ;   et al.
2014-04-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140094471 - Bruncko; Milan ;   et al.
2014-04-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140088106 - Bruncko; Milan ;   et al.
2014-03-27
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140066621 - Bruncko; Milan ;   et al.
2014-03-06
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140057889 - Bruncko; Milan ;   et al.
2014-02-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140057890 - Bruncko; Milan ;   et al.
2014-02-27
7-substituted Indole Mcl-1 Inhibitors
App 20140051683 - WANG; Xilu ;   et al.
2014-02-20
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 8,586,754 - Bruncko , et al. November 19, 2
2013-11-19
Bcl-2 Selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20130296295 - BRUNCKO; Milan ;   et al.
2013-11-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130267534 - Bruncko; Milan ;   et al.
2013-10-10
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130267514 - Bruncko; Milan ;   et al.
2013-10-10
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,546,399 - Bruncko , et al. October 1, 2
2013-10-01
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130184278 - KUNZER; Aaron R. ;   et al.
2013-07-18
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,426,422 - Hexamer , et al. April 23, 2
2013-04-23
Apoptosis-induced Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130096120 - WANG; LE ;   et al.
2013-04-18
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130096121 - Wang; Le ;   et al.
2013-04-18
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,343,967 - Ding , et al. January 1, 2
2013-01-01
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,338,466 - Kunzer , et al. December 25, 2
2012-12-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20120214796 - Ding; Hong ;   et al.
2012-08-23
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20120190688 - Bruncko; Milan ;   et al.
2012-07-26
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,188,077 - Ding , et al. May 29, 2
2012-05-29
Apoptosis promoters
Grant 8,084,607 - Bruncko , et al. December 27, 2
2011-12-27
7-nonsubstituted Indole Mcl-1 Inhibitors
App 20110263599 - Song; Xiaohong ;   et al.
2011-10-27
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20110237553 - Ding; Hong ;   et al.
2011-09-29
1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives
Grant 7,981,888 - Song , et al. July 19, 2
2011-07-19
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20110124628 - Bruncko; Milan ;   et al.
2011-05-26
Survivin inhibitors
Grant 7,910,742 - Wendt , et al. March 22, 2
2011-03-22
Apoptosis promoters
Grant 7,906,505 - Bruncko , et al. March 15, 2
2011-03-15
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100305122 - Bruncko; Milan ;   et al.
2010-12-02
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20100298321 - Bruncko; Milan ;   et al.
2010-11-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100298323 - Bruncko; Milan ;   et al.
2010-11-25
Apoptosis Promoters
App 20100249133 - Bruncko; Milan ;   et al.
2010-09-30
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100184766 - Kunzer; Aaron R. ;   et al.
2010-07-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100184750 - Hexamer; Laura A. ;   et al.
2010-07-22
N-acylsulfonamide apoptosis promoters
Grant 7,754,886 - Augeri , et al. July 13, 2
2010-07-13
Apoptosis promoters
Grant 7,709,467 - Bruncko , et al. May 4, 2
2010-05-04
N-acylsulfonamide Apoptosis Promoters
App 20090137585 - Augeri; David J. ;   et al.
2009-05-28
7-nonsubstituted Indole Mcl-1 Inhibitors
App 20090124616 - Song; Xiaohong ;   et al.
2009-05-14
N-acylsulfonamide apoptosis promoters
Grant 7,504,512 - Augeri , et al. March 17, 2
2009-03-17
7-substituted Indole Mcl-1 Inhibitors
App 20090054402 - Wang; Xilu ;   et al.
2009-02-26
Apoptosis Promoters
App 20080287419 - Bruncko; Milan ;   et al.
2008-11-20
Apoptosis promoters
Grant 7,390,799 - Bruncko , et al. June 24, 2
2008-06-24
Survivin inhibitors
App 20070072833 - Wendt; Michael D. ;   et al.
2007-03-29
Apoptosis promoters
App 20070027135 - Bruncko; Milan ;   et al.
2007-02-01
N-acylsulfonamide apoptosis promoters
App 20040192681 - Augeri, David J. ;   et al.
2004-09-30
N-acylsulfonamide apoptosis promoters
Grant 6,720,338 - Augeri , et al. April 13, 2
2004-04-13
N-Acylsulfonamide apoptosis promoters
App 20020086887 - Augeri, David J. ;   et al.
2002-07-04
N-acylsulfonamide apoptosis promoters
App 20020055631 - Augeri, David J. ;   et al.
2002-05-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed